Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

24 April 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

72423 result(s) found, displaying 65926 to 65950

PEGATRON COMBINATION THERAPY peginterferon alfa-2b (rbe) 100 microgram powder for injection/capsule/diluent composite pack Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEGATRON COMBINATION THERAPY peginterferon alfa-2b (rbe) 120 microgram powder for injection/capsule/diluent composite pack Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEGATRON COMBINATION THERAPY peginterferon alfa-2b (rbe) 150 microgram powder for injection/capsule/diluent composite pack Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEGATRON COMBINATION THERAPY peginterferon alfa-2b (rbe) 50 microgram powder for injection/capsule/diluent composite pack Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEGATRON COMBINATION THERAPY peginterferon alfa-2b (rbe) 80 microgram powder for injection/capsule/diluent composite pack Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEG-INTRON REDIPEN INJECTOR peginterferon alfa-2b (rbe) 100 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEG-INTRON REDIPEN INJECTOR peginterferon alfa-2b (rbe) 120 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEG-INTRON REDIPEN INJECTOR peginterferon alfa-2b (rbe) 150 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEG-INTRON REDIPEN INJECTOR peginterferon alfa-2b (rbe) 50 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEG-INTRON REDIPEN INJECTOR peginterferon alfa-2b (rbe) 80 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
VICTRELIS PEGATRON COMBINATION THERAPY Peg-Intron Redipen (4 x 100mcg) + Rebetol (112 capsules) + Victrelis (336 capsules) Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
VICTRELIS PEGATRON COMBINATION THERAPY Peg-Intron Redipen (4 x 120mcg) + Rebetol (140 capsules) + Victrelis (336 capsules) Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
VICTRELIS PEGATRON COMBINATION THERAPY Peg-Intron Redipen (4 x 150mcg) + Rebetol (140 capsules) + Victrelis (336 capsules) Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
VICTRELIS PEGATRON COMBINATION THERAPY Peg-Intron Redipen (4 x 50mcg) + Rebetol (112 capsules) + Victrelis (336 capsules) Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
Nipro Australia Pty Ltd - Syringe, hypodermic, metered-delivery Cancelled under s41GL(d) of the Act

3 December 2015

Cancellation by sponsor

Requested by Nipro Australia Pty Ltd
Abacus ALS Pty Ltd - Mumps virus IVDs Cancelled under s41GL(d) of the Act

2 December 2015

Cancellation by sponsor

Requested by Abacus ALS Pty Ltd
Abacus ALS Pty Ltd - Varicella zoster virus (Human herpesvirus 3) IVDs Cancelled under s41GL(d) of the Act

2 December 2015

Cancellation by sponsor

Requested by Abacus ALS Pty Ltd
JOHNSON & JOHNSON MEDICAL DISINFECTANTS, WITHOUT CLAIMS 'SODIUM DICHLOROISOCYANURATE' NON-STERILE Cancelled under s30(1)(c) of the Act

2 December 2015

Cancellation by sponsor

Requested by Johnson & Johnson Medical Pty Ltd
USANA Cellsentials HealthPak Cancelled under s30(1)(c) of the Act

2 December 2015

Cancellation by sponsor

Requested by Usana Australia Pty Ltd
USANA Cellsentials Vita-Antioxidant Cancelled under s30(1)(c) of the Act

2 December 2015

Cancellation by sponsor

Requested by Usana Australia Pty Ltd
Bio-Excel (Australia) Pty Ltd - Catheter, angioplasty, balloon dilatation Cancelled under s41GL(d) of the Act

1 December 2015

Cancellation by sponsor

Requested by Bio-Excel Australia Pty Ltd
Bio-Excel Australia Pty Ltd - Catheter balloon inflation system, single-use Cancelled under s41GL(d) of the Act

1 December 2015

Cancellation by sponsor

Requested by Bio-Excel Australia Pty Ltd
ETHYOL amifostine 375mg powder for injection vial Cancelled under s30(1)(c) of the Act

1 December 2015

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
Farabi Health Group Pty Ltd - Absorbent, saliva Cancelled under s41GL(d) of the Act

1 December 2015

Cancellation by sponsor

Requested by Farabi Health Group Pty Ltd
Farabi Health Group Pty Ltd - Absorbent, saliva Cancelled under s41GL(d) of the Act

1 December 2015

Cancellation by sponsor

Requested by Farabi Health Group Pty Ltd

Last updated

24 April 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

PEGATRON COMBINATION THERAPY peginterferon alfa-2b (rbe) 100 microgram powder for injection/capsule/diluent composite pack Cancelled under s30(1)(c) of the Act

PEGATRON COMBINATION THERAPY peginterferon alfa-2b (rbe) 120 microgram powder for injection/capsule/diluent composite pack Cancelled under s30(1)(c) of the Act

PEGATRON COMBINATION THERAPY peginterferon alfa-2b (rbe) 150 microgram powder for injection/capsule/diluent composite pack Cancelled under s30(1)(c) of the Act

PEGATRON COMBINATION THERAPY peginterferon alfa-2b (rbe) 50 microgram powder for injection/capsule/diluent composite pack Cancelled under s30(1)(c) of the Act

PEGATRON COMBINATION THERAPY peginterferon alfa-2b (rbe) 80 microgram powder for injection/capsule/diluent composite pack Cancelled under s30(1)(c) of the Act

PEG-INTRON REDIPEN INJECTOR peginterferon alfa-2b (rbe) 100 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under s30(1)(c) of the Act

PEG-INTRON REDIPEN INJECTOR peginterferon alfa-2b (rbe) 120 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under s30(1)(c) of the Act

PEG-INTRON REDIPEN INJECTOR peginterferon alfa-2b (rbe) 150 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under s30(1)(c) of the Act

PEG-INTRON REDIPEN INJECTOR peginterferon alfa-2b (rbe) 50 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under s30(1)(c) of the Act

PEG-INTRON REDIPEN INJECTOR peginterferon alfa-2b (rbe) 80 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under s30(1)(c) of the Act

VICTRELIS PEGATRON COMBINATION THERAPY Peg-Intron Redipen (4 x 100mcg) + Rebetol (112 capsules) + Victrelis (336 capsules) Cancelled under s30(1)(c) of the Act

VICTRELIS PEGATRON COMBINATION THERAPY Peg-Intron Redipen (4 x 120mcg) + Rebetol (140 capsules) + Victrelis (336 capsules) Cancelled under s30(1)(c) of the Act

VICTRELIS PEGATRON COMBINATION THERAPY Peg-Intron Redipen (4 x 150mcg) + Rebetol (140 capsules) + Victrelis (336 capsules) Cancelled under s30(1)(c) of the Act

VICTRELIS PEGATRON COMBINATION THERAPY Peg-Intron Redipen (4 x 50mcg) + Rebetol (112 capsules) + Victrelis (336 capsules) Cancelled under s30(1)(c) of the Act

Nipro Australia Pty Ltd - Syringe, hypodermic, metered-delivery Cancelled under s41GL(d) of the Act

Abacus ALS Pty Ltd - Mumps virus IVDs Cancelled under s41GL(d) of the Act

Abacus ALS Pty Ltd - Varicella zoster virus (Human herpesvirus 3) IVDs Cancelled under s41GL(d) of the Act

JOHNSON & JOHNSON MEDICAL DISINFECTANTS, WITHOUT CLAIMS 'SODIUM DICHLOROISOCYANURATE' NON-STERILE Cancelled under s30(1)(c) of the Act

USANA Cellsentials HealthPak Cancelled under s30(1)(c) of the Act

USANA Cellsentials Vita-Antioxidant Cancelled under s30(1)(c) of the Act

Bio-Excel (Australia) Pty Ltd - Catheter, angioplasty, balloon dilatation Cancelled under s41GL(d) of the Act

Bio-Excel Australia Pty Ltd - Catheter balloon inflation system, single-use Cancelled under s41GL(d) of the Act

ETHYOL amifostine 375mg powder for injection vial Cancelled under s30(1)(c) of the Act

Farabi Health Group Pty Ltd - Absorbent, saliva Cancelled under s41GL(d) of the Act

Farabi Health Group Pty Ltd - Absorbent, saliva Cancelled under s41GL(d) of the Act

Is there anything wrong with this page?

Site notifications

Cancellations by sponsors

Filter results

Decision type

Date of effect

Is there anything wrong with this page?